CD74 and breast carcinoma: Breast cancer patient P6, a HER2 and hormone receptor-positive breast cancer patient (HER2+, ER+, PR+), with additional metastases in bone, lung and liver, had 16 detectable CTCs, all with a strong or intermediate expression of both CD74 and CD44 (Figure 3A).